Portfolio

Harnessing beneficial bacteria to treat chronic inflammatory skin conditions.

Leading the way in mobile, eyecare diagnostics.

Lentechs, a spinout of The Ohio State University, is developing a novel soft bifocal contact lens.

ControlRad Trace is the first FDA-cleared technology that can be integrated into existing C-arms to reduce radiation in fluoroscopically guided procedure. It reduces radiation exposure by up to 89%, without compromising image quality or workflow.

Natural light therapy for psoriasis, vitiligo, and eczema. The only controlled, connected, and comprehensive solution to treat at home.

Helping patients, making doctors’ lives easier, and decreasing the cost of care by reducing the incidence of false positive blood cultures.

StimGuard is developing products to treat overactive bladder.

Spinal Singularity is developing novel, first to market products in the urology space.

Solving the billion dollar lumbar back pain problem with a novel, first to market, software solution.

Neurvana has developed proprietary, first to market technology to treat cerebral vasospasm and cerebral aneurysms.

Harnessing beneficial bacteria to treat chronic inflammatory skin conditions.
Leading the way in mobile, eyecare diagnostics.
Lentechs, a spinout of The Ohio State University, is developing a novel soft bifocal contact lens.
Lentechs, a spinout of The Ohio State University, is developing a novel soft bifocal contact lens.
ControlRad Trace is the first FDA-cleared technology that can be integrated into existing C-arms to reduce radiation in fluoroscopically guided procedure. It reduces radiation exposure by up to 89%, without compromising image quality or workflow.
Natural light therapy for psoriasis, vitiligo, and eczema. The only controlled, connected, and comprehensive solution to treat at home.
Helping patients, making doctors’ lives easier, and decreasing the cost of care by reducing the incidence of false positive blood cultures.
StimGuard is developing products to treat overactive bladder.
StimGuard is developing products to treat overactive bladder.
Spinal Singularity is developing novel, first to market products in the urology space.
Solving the billion dollar lumbar back pain problem with a novel, first to market, software solution.
Neurvana has developed proprietary, first to market technology to treat cerebral vasospasm and cerebral aneurysms.